ロード中...
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
The candidate malaria vaccine RTS,S has demonstrated 45.7% efficacy over 18 months against all clinical disease in a phase-III field study of African children. RTS,S targets the circumsporozoite protein (CSP), which is expressed on the Plasmodium sporozoite during the pre-erythrocyte stage of its li...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791571/ https://ncbi.nlm.nih.gov/pubmed/28934066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1381809 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|